BioCentury
ARTICLE | Top Story

Celgene raises $1.5B in note deal

August 2, 2013 11:36 PM UTC

Celgene Corp. (NASDAQ:CELG) raised $1.5 billion through the sale of senior unsecured notes. The notes comprise $400 million in 2.3% notes due 2018; $700 million in 4% notes due 2023; and $400 million in 5.25% notes due 2043. Barclays; Citigroup; Deutsche Bank; JPMorgan; and HBSC Securities were underwriters. ...